Urocinasa endopleural: reacción adversa
Leído
7293
Vecesse ha leído el artículo
2197
Total PDF
5096
Total HTML
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 6 | 10 | 12 | 22 |
| 2025 5 | 58 | 58 | 116 |
| 2025 4 | 47 | 59 | 106 |
| 2025 3 | 53 | 41 | 94 |
| 2025 2 | 56 | 21 | 77 |
| 2025 1 | 57 | 22 | 79 |
| 2024 12 | 35 | 30 | 65 |
| 2024 11 | 33 | 60 | 93 |
| 2024 10 | 28 | 31 | 59 |
| 2024 9 | 34 | 34 | 68 |
| 2024 8 | 46 | 46 | 92 |
| 2024 7 | 26 | 32 | 58 |
| 2024 6 | 35 | 24 | 59 |
| 2024 5 | 33 | 31 | 64 |
| 2024 4 | 36 | 25 | 61 |
| 2024 3 | 28 | 35 | 63 |
| 2024 2 | 27 | 44 | 71 |
| 2024 1 | 19 | 29 | 48 |
| 2023 12 | 16 | 10 | 26 |
| 2023 11 | 22 | 16 | 38 |
| 2023 10 | 26 | 23 | 49 |
| 2023 9 | 18 | 19 | 37 |
| 2023 8 | 24 | 29 | 53 |
| 2023 7 | 23 | 48 | 71 |
| 2023 6 | 32 | 29 | 61 |
| 2023 5 | 39 | 23 | 62 |
| 2023 4 | 18 | 19 | 37 |
| 2023 3 | 23 | 35 | 58 |
| 2023 2 | 16 | 24 | 40 |
| 2022 1 | 15 | 21 | 36 |
| 2022 12 | 20 | 26 | 46 |
| 2022 11 | 28 | 45 | 73 |
| 2022 10 | 23 | 36 | 59 |
| 2022 9 | 27 | 39 | 66 |
| 2022 8 | 41 | 39 | 80 |
| 2022 7 | 21 | 36 | 57 |
| 2022 6 | 28 | 30 | 58 |
| 2022 5 | 20 | 31 | 51 |
| 2022 4 | 29 | 36 | 65 |
| 2022 3 | 29 | 37 | 66 |
| 2022 2 | 21 | 26 | 47 |
| 2021 1 | 26 | 34 | 60 |
| 2021 12 | 18 | 29 | 47 |
| 2021 11 | 26 | 42 | 68 |
| 2021 10 | 37 | 32 | 69 |
| 2021 9 | 25 | 41 | 66 |
| 2021 8 | 25 | 30 | 55 |
| 2021 7 | 36 | 32 | 68 |
| 2021 6 | 34 | 30 | 64 |
| 2021 5 | 20 | 23 | 43 |
| 2021 4 | 55 | 57 | 112 |
| 2021 3 | 111 | 20 | 131 |
| 2021 2 | 97 | 21 | 118 |
| 2020 1 | 61 | 20 | 81 |
| 2020 12 | 53 | 12 | 65 |
| 2020 11 | 33 | 2 | 35 |
| 2020 10 | 42 | 5 | 47 |
| 2020 9 | 26 | 9 | 35 |
| 2020 8 | 31 | 14 | 45 |
| 2020 7 | 49 | 10 | 59 |
| 2020 6 | 42 | 5 | 47 |
| 2020 5 | 49 | 13 | 62 |
| 2020 4 | 47 | 12 | 59 |
| 2020 3 | 31 | 9 | 40 |
| 2020 2 | 40 | 17 | 57 |
| 2020 1 | 35 | 19 | 54 |
| 2019 12 | 33 | 16 | 49 |
| 2019 11 | 23 | 11 | 34 |
| 2019 10 | 17 | 4 | 21 |
| 2019 9 | 26 | 25 | 51 |
| 2019 8 | 20 | 15 | 35 |
| 2019 7 | 30 | 24 | 54 |
| 2019 6 | 36 | 34 | 70 |
| 2019 5 | 169 | 44 | 213 |
| 2019 4 | 128 | 22 | 150 |
| 2019 3 | 29 | 15 | 44 |
| 2019 2 | 18 | 15 | 33 |
| 2019 1 | 21 | 14 | 35 |
| 2018 12 | 23 | 11 | 34 |
| 2018 11 | 28 | 10 | 38 |
| 2018 10 | 37 | 19 | 56 |
| 2018 9 | 22 | 5 | 27 |
| 2018 8 | 1 | 0 | 1 |
| 2018 7 | 1 | 0 | 1 |
| 2018 5 | 4 | 0 | 4 |
| 2018 4 | 5 | 0 | 5 |
| 2018 3 | 10 | 0 | 10 |
| 2018 2 | 8 | 0 | 8 |
| 2018 1 | 6 | 0 | 6 |
| 2017 12 | 10 | 0 | 10 |
| 2017 11 | 11 | 0 | 11 |
| 2017 10 | 8 | 0 | 8 |
| 2017 9 | 12 | 0 | 12 |
| 2017 8 | 10 | 0 | 10 |
| 2017 7 | 13 | 2 | 15 |
| 2017 6 | 20 | 6 | 26 |
| 2017 5 | 17 | 6 | 23 |
| 2017 4 | 17 | 6 | 23 |
| 2017 3 | 24 | 10 | 34 |
| 2017 2 | 6 | 3 | 9 |
| 2016 1 | 6 | 3 | 9 |
| 2016 12 | 27 | 5 | 32 |
| 2016 11 | 37 | 6 | 43 |
| 2016 10 | 32 | 7 | 39 |
| 2016 9 | 19 | 2 | 21 |
| 2016 8 | 19 | 4 | 23 |
| 2016 7 | 11 | 4 | 15 |
| 2016 2 | 1 | 0 | 1 |
| 2015 12 | 2 | 0 | 2 |
| 2015 8 | 1 | 0 | 1 |
| 2015 7 | 10 | 0 | 10 |
| 2015 6 | 12 | 0 | 12 |
| 2015 5 | 15 | 0 | 15 |
| 2015 4 | 11 | 0 | 11 |
| 2015 3 | 4 | 0 | 4 |
| 2015 2 | 10 | 0 | 10 |
| 2015 1 | 5 | 0 | 5 |
| 2014 12 | 7 | 0 | 7 |
| 2014 11 | 7 | 0 | 7 |
| 2014 10 | 7 | 0 | 7 |
| 2014 9 | 3 | 0 | 3 |
| 2014 8 | 6 | 0 | 6 |
| 2014 7 | 8 | 0 | 8 |
| 2014 6 | 8 | 0 | 8 |
| 2014 5 | 18 | 0 | 18 |
| 2014 4 | 14 | 0 | 14 |
| 2014 3 | 10 | 0 | 10 |
| 2014 2 | 9 | 0 | 9 |
| 2014 1 | 11 | 0 | 11 |
| 2013 12 | 18 | 0 | 18 |
| 2013 11 | 9 | 0 | 9 |
| 2013 10 | 22 | 0 | 22 |
| 2013 9 | 11 | 0 | 11 |
| 2013 8 | 8 | 0 | 8 |
| 2013 7 | 2 | 0 | 2 |
| 2013 6 | 1 | 0 | 1 |
| 2013 5 | 3 | 0 | 3 |
| 2013 3 | 3 | 0 | 3 |
| 2013 2 | 14 | 0 | 14 |
| 2013 1 | 2 | 0 | 2 |
| 2012 12 | 2 | 0 | 2 |
| 2012 11 | 4 | 0 | 4 |
| 2012 10 | 1 | 0 | 1 |
| 2012 9 | 2 | 0 | 2 |
| 2012 7 | 1 | 0 | 1 |
| 2000 2 | 1551 | 0 | 1551 |
Mostrar todo
